The origins and molecular evolution of SARS-CoV-2 lineage B.1.1.7 in the UK.

"Conflict of interest None declared."

"Funding COG-UK is supported by funding from the Medical Research Council (MRC) part of UK Research & Innovation, the National Institute of Health Research (grant code: MC_PC_19027), and Genome Research Limited, operating as the Wellcome Sanger Institute. V.H. was supported by the Biotechnology and Biological Sciences Research Council (grant number: BB/M010996/1). T.P.P. and W.S.B. are supported by the G2P-UK National Virology Consortium funded by the MRC (grant number: MR/W005611/1). A.R. is also supported by the European Research Council (grant agreement number: 725422—ReservoirDOCs) and the Bill & Melinda Gates Foundation (OPP1175094—HIV-PANGEA II). A.O.T. is supported by the Wellcome Trust Hosts, Pathogens & Global Health Programme (grant number: grant.203783/Z16/Z), and Fast Grants (award number: 2236). D.A. is a Wellcome Clinical PhD Fellow and gratefully supported by the Wellcome Trust (grant number: 222903/Z/21/Z). I.G. is a Wellcome Senior Fellow and is supported by the Wellcome Trust (grant number: 207498/Z/17/Z). E.V. is supported by the Wellcome Trust (Grant number: 220885/Z/20/Z)."